Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$0.21 - $0.32 $6,323 - $9,635
-30,111 Reduced 23.65%
97,182 $23,000
Q2 2023

Aug 09, 2023

SELL
$0.15 - $0.27 $6,480 - $11,664
-43,200 Reduced 25.34%
127,293 $29,000
Q1 2023

May 12, 2023

SELL
$0.13 - $0.19 $12,932 - $18,901
-99,479 Reduced 36.85%
170,493 $28,000
Q4 2022

Feb 09, 2023

SELL
$0.11 - $0.16 $2,546 - $3,703
-23,146 Reduced 7.9%
269,972 $32,000
Q3 2022

Nov 09, 2022

BUY
$0.15 - $2.1 $16,462 - $230,470
109,748 Added 59.85%
293,118 $46,000
Q2 2022

Aug 11, 2022

BUY
$1.22 - $1.95 $211,551 - $338,135
173,403 Added 1739.77%
183,370 $295,000
Q1 2022

May 12, 2022

SELL
$1.15 - $1.97 $16,917 - $28,980
-14,711 Reduced 59.61%
9,967 $17,000
Q4 2021

Feb 11, 2022

SELL
$1.92 - $2.53 $30,241 - $39,850
-15,751 Reduced 38.96%
24,678 $49,000
Q3 2021

Nov 12, 2021

SELL
$1.94 - $2.55 $1,390 - $1,828
-717 Reduced 1.74%
40,429 $83,000
Q2 2021

Aug 10, 2021

BUY
$1.69 - $2.67 $56,135 - $88,686
33,216 Added 418.87%
41,146 $98,000
Q1 2021

May 12, 2021

BUY
$1.79 - $2.91 $14,194 - $23,076
7,930 New
7,930 $16,000
Q1 2020

May 13, 2020

SELL
$0.96 - $1.57 $5,376 - $8,792
-5,600 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$1.1 - $1.32 $6,160 - $7,392
5,600 New
5,600 $7,000
Q2 2019

Aug 09, 2019

SELL
$1.16 - $1.53 $16,665 - $21,981
-14,367 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$0.94 - $1.75 $1,316 - $2,450
-1,400 Reduced 8.88%
14,367 $22,000
Q4 2018

Feb 06, 2019

BUY
$0.6 - $1.72 $3,774 - $10,820
6,291 Added 66.39%
15,767 $15,000
Q3 2018

Nov 08, 2018

SELL
$1.55 - $2.17 $30,603 - $42,844
-19,744 Reduced 67.57%
9,476 $15,000
Q2 2018

Aug 14, 2018

SELL
$2.05 - $3.0 $42,461 - $62,139
-20,713 Reduced 41.48%
29,220 $64,000
Q1 2018

May 11, 2018

BUY
$2.27 - $8.5 $21,117 - $79,075
9,303 Added 22.9%
49,933 $115,000
Q4 2017

Feb 09, 2018

BUY
$5.65 - $9.0 $229,559 - $365,670
40,630
40,630 $288,000

Others Institutions Holding VBLT

About Vascular Biogenics Ltd.


  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.